INTELLECTUAL PROPERTY SPONSORED BIOGRAPHIES
STEVEN LIEBERMAN ROTHWELL, FIGG, ERNST & MANBECK, P.C. 607 14th Street NW, Suite 800 Washington, D.C. 20005 Tel: 202 783 6040 Email: [email protected] Web: www.rothwellfigg.com PAUL J. SKIERMONT SKIERMONT PUCKETT LLP 2200 Ross Ave., Suite 4301W Dallas, Texas 75201 Tel: 214 978 6600 Fax: 214 978 6601 Email: [email protected] Web: www.skiermontpuckett.com Mr. Paul J. Skiermont is a trial lawyer with a national litigation practice focused on patent litigation and other complex commercial litigation. He is a founding partner at SKIERMONT PUCKETT LLP, located in Dallas, Texas. Prior to forming SKIERMONT PUCKETT, Mr. Skiermont was a partner at BARTLIT BECK HERMAN PALENCHAR & SCOTT LLP. Mr. Skiermont and his firm represent companies of all sizes in litigation involving complex science and technology, including pharmaceutical products and other life sciences, aerospace, telecommunications, speech recognition and consumer electronics. SKIERMONT PUCKETT prefers to avoid billing clients by the hour. The firm uses a variety of alternative fee agreements based on the value of its work to its clients, rather than the number of hours billed. You can read more about SKIERMONT PUCKETT’s innovative approach to complex litigation and alternative fees at www.skiermontpuckett.com. Mr. Skiermont has substantial experience representing pharmaceutical companies in Hatch-Waxman patent litigation. For example, Mr. Skiermont represented the patent holder in Hatch-Waxman patent litigation against five generic drug manufacturers who sold or sought approval to sell generic versions of the YAZ® oral contraceptive. After two generic drug manufacturers had launched generic versions of YAZ® “at risk” of later being found to have infringed a valid and enforceable patent, the Federal District Court for the District of Nevada granted Bayer’s motions for summary judgment of validity, infringement, and enforceability against three generic drug manufacturers. On appeal, the Federal Circuit reversed and a motion for panel and en banc rehearing is pending. Mr. Skiermont has also represented clients in Lanham Act false advertising and patent infringement cases. One such case arose from the launch of a competing generic version of an oral contraceptive with product literature claiming that the generic contained a patented formulation when the product did not contain such a formulation. After moving for a temporary restraining order, the court read a tentative ruling during the proceedings finding that Mr. Skiermont’s client was entitled to a TRO. The defendant agreed to remedial measures including a weekly e-mail blast for three months directed at pharmacists correcting the false prescribing information. The court entered an order regarding these remedial measures and required compliance reporting from the generic manufacturer. Mr. Skiermont earned his undergraduate degree with honors from the University of Kentucky. While an undergraduate, he was twice awarded FIRST PLACE SPEAKER at the Intercollegiate National Debate Tournament; one of only three people to win the award twice since the Tournament began in 1947. Prior to law school, Mr.